Panels 3 – 5
PANEL 3: Drug Quality – Substandard and Spurious Drugs: Issues and solutions
Location: Ballroom 1-2
Theme: African drug market is projected to increase (2013-2020) by 200%, and it is estimated that in 2020 the pharmaceuticals market in Africa will reach a size of $45 billion. To ensure effective delivery of health, however, it is crucial to develop policies that guarantee a high quality of the drugs that reach the African markets. According to the London School of Hygiene and Tropical Medicine estimates that falsified or substandard malaria medication account for an additional 116,000 deaths each year. The cost to patients and health ministries of these fake drugs is about $38.5 million§.
The drug quality problem has multiple dimensions including degraded drugs, accidental production errors, intentionally poor quality of drug by recognized manufacturers, or what looks like drugs but has no active ingredients, or those produced by unrecognized pharmaceutical companies. Each of these issues present different challenges and require different solutions. This panel will attempt to address some of these issues and possible solutions.
Moderator: Yehuda Bassok, University of Southern California, Los Angeles (USA)
Panelists:
- Elizabeth Pisani, Associate Professor, School of Health Policy and Management, Erasmus University, Rotterdam
- Amanda Lotheringen, Head of Patents and Copy Protection, Department of Trade , Government of South Africa
- Emile Malan, CEO, Vicore Health, Johannesburg, S. Africa
- David Katerere, PharmaConnect Africa NPO
- Chinedum Chijioke, CEO, Sproxil Africa
PANEL 4: Healthcare Entrepreneurship in Africa
Location: Tau
Theme: In order to meet the challenging needs of health of the population, we need all actors – public, private and entrepreneurs to play a role. Entrepreneurship is the process of designing, launching and running a business that attempts to serve specific needs of its customers. Healthcare is an important domain for entrepreneurship. This panel has assembled entrepreneurs from various segments of the healthcare value chain to explore progress and challenges of entrepreneurs in healthcare space in sub-saharan Africa.
Moderator: Ravi Anupindi, Ross School of Business, University of Michigan
Panelists:
- Tom Kirengo, Chairman, Executive Director, Imara Mediplus
- Patricia Ekuba Odoi-Atsem, CEO, 3M&C Health Systems
- Tiroyaone Mampane, President, Boitekanelo Group
- Cosmas Mukaratirwa, Cospharm
PANEL 5: Procurement Mechanisms and Capacity Development for Transitioning Countries
Location: Ballroom 3
Objective: Discuss the role of procurement mechanisms in the context of graduating countries with consideration for local regulation, procurement capacity, devolution, private sector healthcare actors and procurement marketplaces.
Description: Over the past two decades, development partners have funded initiatives that have dramatically improved the availability, affordability and quality of lifesaving medicines and diagnostics through improved procurement practices i.e. market shaping, advanced market commitments and pooled procurement. As low and middle-income countries progress economically, their governments are taking on more of the financial responsibility for their healthcare services and with that procurement of medicines and diagnostics.
In this session we will explore the relevance of these global practices as countries transition and what mechanisms/approaches are best suited to ensure the continuity and quality of supply and the ongoing introduction of innovative products. With the advent of technology, we will also explore the role of virtual marketplaces/platforms, and how to ensure alignment with local regulations, quality of supply and contract management
Moderator: Maeve Magner, Advisor | Board Member | Start Up Mentor | Global Health Expert
Panelists:
- Jessica Vernon, Maisha Meds
- Alfons Van Woerkom, Global Fund
- Annemarie Haverhals, I+ Solutions
- Hemant Harrielall, CIPS